Perlen, 2 November 2017 – The Chemistry Division of CPH Chemie + Papier Holding AG is to acquire Armar AG with effect from 1 March 2018. Armar, which was founded in 1986 and is domiciled in Do?ttingen, Canton Aargau, Switzerland, manufactures and distributes deuterated solvents, and is a long-established distribution partner of the CPH Group. The company achieves regular profits on annual sales in the mid-single-digit million Swiss francs region.

Under the sale agreement, Zeochem AG will acquire the assets of Armar AG and integrate the company’s current production into its operations at its new Ru?ti (Canton Zurich) location. Adrian Geiger, the shareholder and CEO of Armar, has thus made the arrangements for his own succession. Geiger will also move to Zeochem with the transfer of the business. The deal further ensures long-term continuity and product quality for Armar’s customers. The parties have agreed not to divulge the sale price involved.

“In effecting this acquisition, we are strengthening our position in the deuterated solvents market, and can now further expand our business in this highly specialized field,” says Peter Schildknecht, CEO of the CPH Group. Deuterated products are used as synthetic building blocks in pharmaceutical agents, in NMR spectroscopy and for the production of organic light- emitting diodes or OLEDs.

Contacts

CPH Chemie + Papier Holding AG
Dr. Peter Schildknecht, CEO, +41 41 455 87 57, investor.relations@cph.ch
Christian Weber, Head of Corporate Communications, +41 41 455 87 51, medien@cph.ch

Download document (PDF, 75kb, EN)